Seqirus to build fill-and-finish facility at Liverpool site

Seqirus announced a major investment to build a new fill-and-finish facility at its Liverpool manufacturing site, creating 88 new high-tech jobs. The facility will bring in-house the filling of adjuvanted influenza vaccine, currently done by a contract manufacturer in Italy.

“Nearly a hundred new high tech jobs are to be created at the Liverpool manufacturing site of Seqirus as a result of major new investment announced today.”newsroom.csl.com

• 1 source
• newsroom.csl.comNews Releases | CSLNov 8, 2017

Summarized from public sources; check the original articles before acting on it.